GWPH Stock Ownership Activity

GW PHARMACEUTICALS -ADR 13F holders

No value investing guru has made any change to the GW PHARMACEUTICALS -ADR (GWPH) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying GWPH now?

According to the latest SEC filing(s) GW PHARMACEUTICALS -ADR (GWPH) has not been purchased by any super investor.

To see more about who is investing in GW PHARMACEUTICALS -ADR (GWPH), please go to the GWPH ownership page.

2018 Q1 (1 result)
Ole Andreas Halvorsen
-100.00%
-211,869
-0.17%
0.00%
Reported price*: $132.01
2017 Q4 (1 result)
Ole Andreas Halvorsen
-69.90%
-491,987
-0.40%
0.00%
Reported price*: $132.01
2017 Q3 (1 result)
Ole Andreas Halvorsen
-19.40%
-169,452
-0.11%
0.46%
Reported price*: $101.49
2017 Q2 (1 result)
Ole Andreas Halvorsen
+4.64%
+33,091
+0.03%
0.50%
Reported price*: $100.25
2017 Q1 (1 result)
Ole Andreas Halvorsen
-8.37%
-49,928
-0.04%
0.29%
Reported price*: $120.94
2016 Q4 (1 result)
Ole Andreas Halvorsen
-7.31%
-71,824
-0.04%
0.46%
Reported price*: $111.75
2016 Q3 (1 result)
Ole Andreas Halvorsen
+18.17%
+151,108
+0.09%
0.56%
Reported price*: $132.73
2016 Q2 (1 result)
Ole Andreas Halvorsen
buy
+831,547
+0.32%
0.32%
Reported price*: $91.57
8 of 8

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.